<?xml version="1.0"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
    "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta name="generator"
    content="HTML Tidy for FreeBSD (vers 1st April 2002), see www.w3.org" />
    <base
    href="http://www.cirp.org/library/disease/mills-siegfried2006/" />

    <title>Trials of Circumcision to Prevent HIV Infection May
    Overstate Effect When Stopped Early.</title>
    <meta name="robots" content="index, follow" />
    <meta name="keywords"
    content="circumcision, conversion, dissociative disorder, hysteria, posterior urethral valves, urinary retention" />
    <meta name="description"
    content="A letter from a medical journal." />
    <script type="text/javascript" language="JavaScript">
    //<![CDATA[
// bust out of a frame
<!-- hide
var caught = 0;
if (top.frames.length != 0) {
  caught++;
  if (caught != 0)
  {
    top.location=self.document.location;
  }
}
// end hide -->
    //]]>
    </script>

    <style type="text/css">
/*<![CDATA[*/
<!--
@import "http://www.cirp.org/library/style.css";
h4
{
font-family: arial, helvetica, sans-serif;
}
p.text3
{
font-family: arial, helvetica, sans-serif;
text-align: justify;
font-size: 10.5pt;
}
p.text4
{
font-family: arial, helvetica, sans-serif;
text-align: justify;
text-indent: 1em;
font-size: 10.5pt;
}
p.conflict
{
font-family: arial, helvetica, sans-serif;
font-size: 8pt;
}
p.author
{
font-family: arial, helvetica, sans-serif;
}
ol.lancet
{
font-size: 9pt;
font-family: arial, helvetica, sans-serif;
list-style-position: inside;
list-style: none;
-->
/*]]>*/
    </style>
  </head>

  <body bgcolor="white">
    <p class="library">T<span class="sclibrary">HE</span> C<span
    class="sclibrary">IRCUMCISION</span> R<span
    class="sclibrary">EFERENCE</span> L<span
    class="sclibrary">IBRARY</span></p>
    <hr size="1" color="black" />

    <h3>THE LANCET, Volume 368: Page 1236,<br />
     October 7 2007.</h3>
    <br />
    <br />

    <div class="corpus">
      <h4>Cautious optimism for new HIV/AIDS prevention
      strategies</h4>

      <p class="text3">The 2006 International AIDS Conference,
      showcased in the special (<i>Lancet</i>)<sup>Red</sup> issue,
      was filled with promises for effective prevention strategies.
      Media attention and plenary speeches suggested that effective
      strategies, notably male circumcision and pre-exposure
      prophylaxis (PREP), are imminent.<sup><a
      href="#n1">1</a></sup> Instead we advise cautious
      optimism.</p>

      <p class="text4"><span class="yellow">The inferences drawn
      from the only completed randomised controlled trial (RCT) of
      circumcision could be weak because the trial stopped
      early.</span><sup><a href="#n2">2</a></sup> In a systematic
      review of RCTs stopped early for benefit,<sup><a
      href="#n3">3</a></sup> such RCTs were found to overestimate
      treatment effects. When trials with events fewer than the
      median number (n=66) were compared with those with event
      numbers above the median, the odds ratio for a magnitude of
      effect greater than the median was 28 (95% CI 11&ndash;73).
      The circumcision trial recorded 69 events, and is therefore
      at risk of serious effect overestimation.</p>

      <p class="text4">We therefore advocate an impartial
      meta-analysis of individual patients&rsquo; data from this
      and other trials underway before further feasibility studies
      are done.</p>

      <p class="text4">Although the rationale for PREP is exciting,
      researchers have leapt from small (n=6&ndash;18) and
      inconsistent nonrandomised monkey studies into multicentred
      trials.<sup><a href="#n4">4</a></sup> The first PREP trial
      results were provided at the conference,<sup><a
      href="#n5">5</a></sup> but had an insufficient number of
      infections to provide any inferences about effectiveness (two
      of 363 vs six of 368).</p>

      <p class="text4">New interventions are required to slow the
      HIV/AIDS pandemic. Disappointments stemming from media hype
      and misinterpretation of early trials can make policy and
      recruitment of appropriate trial populations difficult. If we
      are to alter the epidemic&rsquo;s progress, we should be
      methodologically rigorous, and cautiously optimistic about
      the potential for new interventions.</p>

      <p class="conflict">We declare that we have no conflict of
      interest.</p>

      <p class="author"><i>*Edward Mills, Nandi Siegfried</i><br />
       <a href="mailto:emills@cihhrs.org">emills@cihhrs.org</a></p>

      <p class="conflict"><a href="http://www.cihhrs.org/"
      target="_blank">Centre for International Health and Human
      Rights Studies</a>, 1255 Sheppard Avenue East, Toronto,
      Ontario M2K 1E2, Canada (EM); and Clinical Trial Service
      Unit, <a href="http://www.ndm.ox.ac.uk/"
      target="_blank">Department of Medicine</a>, <a
      href="http://www.ox.ac.uk/" target="_blank">University of
      Oxford</a>, Oxford, UK (NS)</p>

      <ol class="lancet">
        <li><a id="n1" name="n1"></a>1 Saletan W. When cutting
        isn&rsquo;t cruel. <b><i>Washington Post</i></b> Aug 20,
        2006: B02.</li>

        <li><a id="n2" name="n2"></a>2 Siegfried N. Does male
        circumcision prevent HIV infection? <b><i>PLoS Med</i></b>
        2005; <b>2</b>: e393. [<a
        href="http://medicine.plosjournals.org/perlserv?request=get-document&amp;doi=10.1371/journal.pmed.0020393"
         target="_blank">Full Text</a>]</li>

        <li><a id="n3" name="n3"></a>3 Montori VM, Devereaux PJ,
        Adhikari NK, et al. Randomized trials stopped early for
        benefit: a systematic review. <b><i>JAMA</i></b> 2005;
        <b>294</b>: 2203&ndash;09. [<a
        href="http://jama.ama-assn.org/cgi/content/abstract/294/17/2203"
         target="_blank">Abstract</a>]</li>

        <li><a id="n4" name="n4"></a>4 Mills EJ, Singh S, Singh JA,
        Orbinski JJ, Warren M, Upshur RE. Designing research in
        vulnerable populations: lessons from HIV prevention trials
        that stopped early. <b><i>BMJ</i></b> 2005; <b>331</b>:
        1403&ndash;06. [<a
        href="http://www.bmj.com/cgi/content/full/331/7529/1403"
        target="_blank">Full Text</a>]</li>

        <li><a id="n5" name="n5"></a>5 Peterson L, Taylor D, Clarke
        EEK, et al. Findings from a double-blind, randomized,
        placebocontrolled trial of tenofovir disoproxil fumarate
        (TDF) for prevention of HIV infection in women. XVI
        International AIDS Conference; Toronto, Canada; Aug 17,
        2006.</li>
      </ol>
    </div>
    <hr />

    Citation:
    <ul>
      <li>Mills J, Siegfried N. Cautious optimism for new HIV/AIDS
      prevention strategies. <i>Lancet</i> 2006;368:1236.</li>
    </ul>
    <hr />

    <small>(File created 9 March 2007)</small>

    <center>
      <p class="navlink"><a href="/library/">Return to CIRP
      Library</a></p>
    </center>

    <p>
    <tt>http://www.cirp.org/library/disease/HIV/mills-siegfried2006/</tt></p>
  </body>
</html>
